When the germline origin of the pathogenic TP53 variant is suspected based on non-tumor sequencing, it is advisable to confirm the result from independent tissue, according to the guidelines for testing in hematopoietic malignancies [102]. This evidence concerns the gene TP53 and neoplasm.